Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1800 of 2051 entries
View as:

Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)

Phase: N/A Priority: Normal
NCT ID: NCT03524118 Org: User:
Start: 09/20/18 End: 09/14/22 Due: 09/14/23

The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00421278 Org: User:
Start: 11/30/06 End: 01/31/07 Due: 01/31/08

Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)

Phase: N/A Priority: Normal
NCT ID: NCT04221945 Org: User:
Start: 05/12/20 End: 01/17/26 Due: 01/17/27

International Registry on Cardioversion of Atrial Fibrillation (MK-6621-051)

Phase: N/A Priority: Normal
NCT ID: NCT01119716 Org: User:
Start: 05/25/10 End: 02/15/13 Due: 02/15/14

A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00239655 Org: User:
Start: 08/31/04 End: 01/31/06 Due: 01/31/07

Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060)

Phase: N/A Priority: Normal
NCT ID: NCT02105467 Org: User:
Start: 06/05/14 End: 09/06/15 Due: 09/06/16

A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)

Phase: N/A Priority: Normal
NCT ID: NCT07013487 Org: User:
Start: 06/11/25 End: 02/02/32 Due: 02/02/33

Study to Evaluate the Pharmacokinetics & Food Effect of MK-0941 in Adults With Type 2 Diabetes (MK-0941-009)

Phase: N/A Priority: Normal
NCT ID: NCT00567112 Org: User:
Start: 11/30/07 End: 04/30/08 Due: 04/30/09

A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048)

Phase: N/A Priority: Normal
NCT ID: NCT00961857 Org: User:
Start: 12/01/05 End: 01/01/06 Due: 01/01/07

A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)

Phase: N/A Priority: Normal
NCT ID: NCT01557504 Org: User:
Start: 07/18/12 End: 04/29/14 Due: 04/29/15

Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)

Phase: N/A Priority: Normal
NCT ID: NCT01177384 Org: User:
Start: 01/25/11 End: 03/25/13 Due: 03/25/14

Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)

Phase: N/A Priority: Normal
NCT ID: NCT01590225 Org: User:
Start: 01/28/13 End: 08/18/21 Due: 08/18/22

V501 Efficacy Study in Women Aged 18 to 26 (V501-027)

Phase: N/A Priority: Normal
NCT ID: NCT00378560 Org: User:
Start: 06/12/06 End: 09/16/09 Due: 09/16/10

Bioequivalence of Two Tablet Forms of MK0974 (0974-045)

Phase: N/A Priority: Normal
NCT ID: NCT00965887 Org: User:
Start: 03/31/08 End: 05/31/08 Due: 05/31/09

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)

Phase: N/A Priority: Normal
NCT ID: NCT03565900 Org: User:
Start: 09/12/18 End: 11/04/21 Due: 11/04/22

Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)

Phase: N/A Priority: Normal
NCT ID: NCT03976323 Org: User:
Start: 06/28/19 End: 12/31/25 Due: 12/31/26

Study of Gefapixant (MK-7264) in Acute Cough for Participants With Induced Viral Upper Respiratory Tract Infection (URTI) (MK-7264-013)

Phase: N/A Priority: Normal
NCT ID: NCT03569033 Org: User:
Start: 07/04/18 End: 11/19/18 Due: 11/19/19

Neuropathic Pain Syndrome Patient Study (MK-0000-072)

Phase: N/A Priority: Normal
NCT ID: NCT00570310 Org: User:
Start: 12/31/07 End: 09/30/08 Due: 09/30/09

ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)

Phase: N/A Priority: Normal
NCT ID: NCT01600079 Org: User:
Start: 05/15/12 End: 10/16/20 Due: 10/16/21

Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)

Phase: N/A Priority: Normal
NCT ID: NCT00564421 Org: User:
Start: 12/18/07 End: 02/14/08 Due: 02/14/09

Developing World Study for RotaTeq™ (V260-015)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00362648 Org: User:
Start: 03/31/07 End: 03/31/09 Due: 03/31/10

MK0457 in Patients With Leukemia (0457-003)

Phase: N/A Priority: Normal
NCT ID: NCT00111683 Org: User:
Start: 06/30/05 End: 05/31/08 Due: 05/31/09

A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)

Phase: N/A Priority: Normal
NCT ID: NCT00746694 Org: User:
Start: 10/31/07 End: 06/30/09 Due: 06/30/10

Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058)

Phase: N/A Priority: Normal
NCT ID: NCT00423449 Org: User:
Start: 03/31/07 End: 04/30/10 Due: 04/30/11

A Study to Evaluate Laser Speckle Contrast Imaging to Assess Changes in Chemical Agent-Induced Skin Blood Flow in Healthy Participants (MK-0000-420)

Phase: N/A Priority: Normal
NCT ID: NCT06809569 Org: User:
Start: 09/25/23 End: 12/15/23 Due: 12/15/24